Skip to content

CONMED CNMD Interest coverage

Interest coverage at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
24.5×-1.7×
Stryker logo
StrykerSYK
-3.0×
Boston Scientific logo
Boston ScientificBSX
10.6×+1.7×
Vericel logo
VericelVCEL
24.8×+21.4×
Medtronic logo
MedtronicMDT
9.1×+0.9×
IAR
Integra LifeSciencesIART
-5.4×-5.6×

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Calculated from CONMED’s reported figures.

Based on trailing twelve months.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's interest coverage?
CONMED (CNMD) reported interest coverage of 3.8× in Q1 2026.
How has CONMED's interest coverage changed year-over-year?
CONMED's interest coverage decreased by 25.5% year-over-year, from 5× to 3.8×.
What is the long-term trend for CONMED's interest coverage?
Over 5 years (2020 to 2025), CONMED's interest coverage has grown at a 25.9% compound annual growth rate (CAGR), from 1× to 3.3×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.